ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,544,415, issued on Feb. 10, was assigned to Transgene (Illkirch Graffenstaden, France).
"Immunotherapeutic vaccine and antibody combination therapy" was invented by Philippe Slos (Ingwiller, France), Julie Hortelano (Illkirch, France), Karola Rittner (Strasbourg, France) and Xavier Preville (Saint Louis, France).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a combination product, composition(s) and kit of parts comprising at least (i) a therapeutic vaccine and (ii) one or more immune checkpoint modulator(s). The present invention also concerns a method for treating a proliferative or an infectious disease as well as a me...